<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Zhou Y</submitter><pubmed_abstract>The metabolic microenvironment of bacteria impacts drug efficacy. However, the metabolic mechanisms of drug-resistant &lt;i>Salmonella&lt;/i> spp. remain largely unknown. This study characterized the metabolic mechanism of gentamicin-resistant &lt;i>Salmonella&lt;/i> Choleraesuis and found that D-ribose increased the gentamicin-mediated killing of this bacteria. Non-targeted metabolomics of homologous gentamicin-susceptible &lt;i>Salmonella&lt;/i> Choleraesuis (SCH-S) and gentamicin-resistant &lt;i>S.&lt;/i> Choleraesuis (SCH-R) was performed using UHPLC-Q-TOF MS. The metabolic signature of SCH-R included disrupted central carbon metabolism and energy metabolism, along with dysregulated amino acid and nucleotide metabolism, vitamin and cofactor metabolism, and fatty acid synthesis. D-ribose, the most suppressed m</pubmed_abstract><journal>Frontiers in microbiology</journal><pagination>1053330</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9676500</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Exogenous D-ribose promotes gentamicin treatment of several drug-resistant &lt;i>Salmonella&lt;/i>.</pubmed_title><pmcid>PMC9676500</pmcid><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Yong Y</pubmed_authors><pubmed_authors>Fang B</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Zhu C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exogenous D-ribose promotes gentamicin treatment of several drug-resistant &lt;i>Salmonella&lt;/i>.</name><description>The metabolic microenvironment of bacteria impacts drug efficacy. However, the metabolic mechanisms of drug-resistant &lt;i>Salmonella&lt;/i> spp. remain largely unknown. This study characterized the metabolic mechanism of gentamicin-resistant &lt;i>Salmonella&lt;/i> Choleraesuis and found that D-ribose increased the gentamicin-mediated killing of this bacteria. Non-targeted metabolomics of homologous gentamicin-susceptible &lt;i>Salmonella&lt;/i> Choleraesuis (SCH-S) and gentamicin-resistant &lt;i>S.&lt;/i> Choleraesuis (SCH-R) was performed using UHPLC-Q-TOF MS. The metabolic signature of SCH-R included disrupted central carbon metabolism and energy metabolism, along with dysregulated amino acid and nucleotide metabolism, vitamin and cofactor metabolism, and fatty acid synthesis. D-ribose, the most suppressed m</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-07-14T16:56:01.146Z</modification><creation>2024-11-20T23:30:59.844Z</creation></dates><accession>S-EPMC9676500</accession><cross_references><pubmed>36419438</pubmed><doi>10.3389/fmicb.2022.1053330</doi></cross_references></HashMap>